論文・技術情報追加のお知らせ

①A Real-World Disproportionality Analysis of Drug-Induced Immune Hemolytic Anemia in the FDA Adverse Event Reporting System.

免疫性溶血性貧血誘発リスクがある薬剤探索研究

対象DB：FAERS

②Post-marketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System.

六価ワクチンの安全性評価研究

対象DB：VAERS

③Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system.

オシメルチニブに関する有害事象の性差調査研究

対象DB：FAERS

④Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of Clostridium difficile Infection Associated with Antibacterial Drug Exposure.

抗菌薬曝露によるクロストリジウム・ディフィシル感染症のリスク評価研究

対象DB：FAERS

⑤Perspective: Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults.

成人におけるマグネシウム補給の耐容上限摂取量評価研究

対象DB：FAERS,CAERS

⑥Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database.

乾癬および関節症性乾癬治療における、リサンキズマブの安全性評価研究

対象DB：EudraVigilance

⑦Antifungal Drug-Drug Interactions with Commonly Used Pharmaceutics in European Pediatric Patients with Acute Lymphoblastic Leukemia.

小児急性リンパ芽球性白血病患者における、一般的に使用される薬剤と抗真菌薬との相互作用調査研究

対象DB：EudraVigilance